Study Name: Alisertib (MLN8237) or Investigator's Choice in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma
25 locations found
- Hackensack University Medical Center
Location: Hackensack, New Jersey
- Dartmouth
Location: Lebanon, New Hampshire 03755
- Fletcher Allen Health Care
Location: Burlington, Vermont 05401
- Columbia University Medical Center
Location: New York, New York 10016
- Weill Cornell Medical College
Location: New York, New York 10021
- SUNY Upstate Medical Center
Location: Syracuse, New York 13210
- University of Virginia
Location: Charlottesville, Virginia 22903
- Mary Babb Randolph Cancer Center
Location: Morgantown, West Virginia 26506
- Duke University Medical Center
Location: Durham, North Carolina 27705
- Medical University of South Carolina
Location: Charleston, South Carolina 29425
- MD Anderson Cancer Center Orlando
Location: Orlando, Florida 32806
- AMPM Research Clinic
Location: Miami, Florida 33145
- H. Lee Moffitt Cancer Center & Research Institute
Location: Tampa, Florida 33647
- Vanderbilt University Medical Center
Location: Nashville, Tennessee 37232
- Providence Saint Joseph Medical Center
Location: Burbank, California 91505
- University of Iowa Hospitals & Clinics
Location: Iowa City, Iowa 52242
- University of Kansas Medical Center
Location: Kansas City, Kansas 66205
- Henry Ford Health System
Location: Detriot, Michigan 48202
- Karmanos Cancer Institute
Location: Detroit, Michigan 48201
- Mayo Clinic Rochester
Location: Rochester, Minnesota 55905
- Columbia Comprehensive Cancer Care Clinic
Location: Jefferson City, Missouri 65109
- ProMedica Health System, Inc.
Location: Sylvania, Ohio 43560
- Mercy St. Vincent Medical Center
Location: Toledo, Ohio 43623
- Methodist Hospital
Location: Houston, Texas 78229
- Seattle Cancer Care
Location: Seattle, Washington 98109
|